EMSAM (deprenyl patch): how a promising antidepressant was underutilized [Corrigendum]

EMSAM (deprenyl patch): how a promising antidepressant was underutilized [Corrigendum]

Asnis GM, Henderson MA. Neuropsychiatr Dis Treat. 2014;10:1911–1923.On page 1921 “[…] Dye and now Mylan Pharmaceutical took over the marketing of EMSAM from Bristol-Myers Squibb” should be “Dey and now Mylan Pharmaceutical took over the marketing o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Asnis GM, Henderson MA
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Acceso en línea:https://doaj.org/article/41acde07226d49a9b1fe02a82eac6b89
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:41acde07226d49a9b1fe02a82eac6b89
record_format dspace
spelling oai:doaj.org-article:41acde07226d49a9b1fe02a82eac6b892021-12-02T00:35:48ZEMSAM (deprenyl patch): how a promising antidepressant was underutilized [Corrigendum]1178-2021https://doaj.org/article/41acde07226d49a9b1fe02a82eac6b892014-11-01T00:00:00Zhttp://www.dovepress.com/corrigendum-emsam-deprenyl-patch-how-a-promising-antidepressant-w-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021 Asnis GM, Henderson MA. Neuropsychiatr Dis Treat. 2014;10:1911–1923.On page 1921 “[…] Dye and now Mylan Pharmaceutical took over the marketing of EMSAM from Bristol-Myers Squibb” should be “Dey and now Mylan Pharmaceutical took over the marketing of EMSAM from Bristol-Myers Squibb”.On page 1921 “Both Dye and Mylan’s recent attempts at reanalysis […]” should be “Both Dey and Mylan’s recent attempts at reanalysis […]”.On page 1921 “With over 14 years left in the patent of EMSAM, [...]” should be “with 4 years left in the patent of EMSAM, [...]”. The authors apologize for these errors.Read the original articleAsnis GMHenderson MADove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2014, Iss default, Pp 2069-2070 (2014)
institution DOAJ
collection DOAJ
language EN
topic Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Asnis GM
Henderson MA
EMSAM (deprenyl patch): how a promising antidepressant was underutilized [Corrigendum]
description Asnis GM, Henderson MA. Neuropsychiatr Dis Treat. 2014;10:1911–1923.On page 1921 “[…] Dye and now Mylan Pharmaceutical took over the marketing of EMSAM from Bristol-Myers Squibb” should be “Dey and now Mylan Pharmaceutical took over the marketing of EMSAM from Bristol-Myers Squibb”.On page 1921 “Both Dye and Mylan’s recent attempts at reanalysis […]” should be “Both Dey and Mylan’s recent attempts at reanalysis […]”.On page 1921 “With over 14 years left in the patent of EMSAM, [...]” should be “with 4 years left in the patent of EMSAM, [...]”. The authors apologize for these errors.Read the original article
format article
author Asnis GM
Henderson MA
author_facet Asnis GM
Henderson MA
author_sort Asnis GM
title EMSAM (deprenyl patch): how a promising antidepressant was underutilized [Corrigendum]
title_short EMSAM (deprenyl patch): how a promising antidepressant was underutilized [Corrigendum]
title_full EMSAM (deprenyl patch): how a promising antidepressant was underutilized [Corrigendum]
title_fullStr EMSAM (deprenyl patch): how a promising antidepressant was underutilized [Corrigendum]
title_full_unstemmed EMSAM (deprenyl patch): how a promising antidepressant was underutilized [Corrigendum]
title_sort emsam (deprenyl patch): how a promising antidepressant was underutilized [corrigendum]
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/41acde07226d49a9b1fe02a82eac6b89
work_keys_str_mv AT asnisgm emsamdeprenylpatchhowapromisingantidepressantwasnbspunderutilizedcorrigendum
AT hendersonma emsamdeprenylpatchhowapromisingantidepressantwasnbspunderutilizedcorrigendum
_version_ 1718403611660124160

Ejemplares similares